跳至主要内容
临床试验/CTRI/2009/091/000667
CTRI/2009/091/000667招募中1 期

Prospective open-labeled clinical study to evaluate the safety and efficacy of R-HSC-001 in patients with Parkinsons Disease.

Reliance Life Science Pvt Ltd0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female of between 35 to 75 years of age.
  • 2. Patients with current diagnosis of PD.
  • 3. Patients with at least 5 years since the disease.
  • 4. Patient is able to comply with and understand the required visit schedule and required tests and procedures.

排除标准

  • 1. History of intracranial surgery.
  • 2. History of malignancy.
  • 3. Contraindication of MRI.
  • 4. Significant coagnitive impairement.
  • 5. Any contraindication to surgery.
  • 6. Abnormal hematology and biochemistry.
  • 7. Positive test result of HBsAg, HCV and HIV.
  • 8. Pregnant and lactating mother.

研究者

发起方
Reliance Life Science Pvt Ltd

相似试验